Impact Biomedical (IBO) Interest & Investment Income (2022 - 2026)
Impact Biomedical (IBO) posted Interest & Investment Income of $5000.0 for Q1 2026, up 66.67% on a QoQ basis from $3000.0 in Q1 2025, and up 66.67% year-over-year from $3000.0 in Q1 2025.
Impact Biomedical (IBO) Interest & Investment Income (2022 - 2026) Analysis & Trends
Impact Biomedical's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $5000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 66.67% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14000.0 (up 16.67% YoY) and the FY2023 annual result came in at $13000.0, down 45.83% from the prior year.
- Interest & Investment Income was $5000.0 for Q1 2026 at Impact Biomedical, up from $3000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $90000.0 in Q2 2022 and bottomed at -$80000.0 in Q4 2022.
- A 5-year average of $3545.5 and a median of $3000.0 in 2022 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 103.75% in 2023, while the deepest fall reached 96.67% in 2023.
- Impact Biomedical's Interest & Investment Income stood at -$80000.0 in 2022, then surged by 103.75% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then surged by 66.67% to $5000.0 in 2026.
- Business Quant data shows IBO's Interest & Investment Income at $5000.0 in Q1 2026, $3000.0 in Q1 2025, and $3000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Impact Biomedical | 47.41 Mn | 47.39 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | -80,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 90,000.00 |